TP53 and breast carcinoma: Therefore, our study focused on the protein content of the Mw fraction between 50 and 100 kDa, which showed the highest activity against tested breast cancer lines MDA-MB-231 (mutant p53), MCF-7 (wild type p53), and the non-tumorigenic MCF-10A cell line.